Drug Research
Drug Discovery & Development

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
91-105 of 4699 results
Roivant Sciences secures rights to develop Ligand’s glucagon receptor antagonist
Ligand Pharmaceuticals has signed a license agreement granting Roivant Sciences exclusive global rights to develop and commercialize its LGD-6972 glucagon receptor antagonist (GRA).
Drug Research > Drug Discovery & Development > News
Caladrius acquires license to CD34+ cell therapy program from Shire
Caladrius Biosciences has acquired an exclusive worldwide license to data from Shire’s late stage CD34+ cell therapy program for the treatment of chronic myocardial ischemia targeting refractory angina.
Drug Research > Drug Discovery & Development > News
Vividion, Celgene partner to develop small molecule therapies
Vividion Therapeutics has partnered with Celgene to discover therapies against transformative, first-in-class targets.
Drug Research > Drug Discovery & Development > News
Research reveals bacteria could be programmed to produce drugs
By PBR Staff Writer
Research into synthetic biology from the Universities of Warwick and Surrey has revealed that bacteria could be programmed to produce drugs.
Drug Research > Drug Discovery & Development > News
Rubius raises $100m funding to further support red-cell therapeutics development
US-based biotechnology company Rubius Therapeutics has raised $100m crossover financing to further support manufacturing and clinical development of red-cell therapeutics.
Drug Research > Drug Discovery & Development > News
Endo wins preliminary injunction against QuVa in vasopressin case
By PBR Staff Writer
Endo International has won a preliminary injunction in the US, barring QuVa Pharm from introducing a compounding drug that could compete with its Vasostrict, the vasopressin injection indicated to increase blood pressure in adults with vasodilatory shock.
Drug Research > Drug Discovery & Development > News
Mylan partners with Revance to develop Botox biosimilar
Mylan has entered into a global collaboration and license agreement with Revance Therapeutics to develop and commercialize a proposed biosimilar to Botox (onabotulinumtoxinA).
Drug Research > Drug Discovery & Development > News
GSK to use Covance’s solutions in global clinical trials portfolio
LabCorp’s Covance Drug Development business has signed a strategic technology agreement with GlaxoSmithKline (GSK).
Drug Research > Drug Discovery & Development > News
AstraZeneca's MedImmune spins out biotech to focus on autoimmune candidates
By PBR Staff Writer
MedImmune, the global biologics research and development arm of AstraZeneca, is creating a stand-alone company for early-stage inflammation and autoimmunity biologics.
Drug Research > Drug Discovery & Development > News
Senti Biosciences secures $53m funding to advance therapeutic design platform
Senti Biosciences has completed a $53m round of funding to support the expansion of their therapeutic design platform.
Drug Research > Drug Discovery & Development > News
Diurnal secures patents for Alkindi and Chronocort in Japan
Diurnal Group, a specialty pharmaceutical company focused on developing treatments for chronic endocrine (hormonal) diseases, has secured patents from the Japanese Patent Office (JPO) for Alkindi (Infacort) and Chronocort.
Drug Research > Drug Discovery & Development > News
BenevolentAI buys drug discovery and development facility in Cambridge, UK
BenevolentAI has acquired an advanced drug discovery and development facility on the Babraham Research Campus in Cambridge, UK, for an undisclosed sum.
Drug Research > Drug Discovery & Development > News
New collaborative project to develop Zika virus vaccine for pregnant women
A new collaborative project has been launched to develop a Zika virus vaccine that is suitable for use in pregnancy.
Drug Research > Drug Discovery & Development > News
Kite, Sangamo form $3bn cancer cell therapy collaboration
By PBR Staff Writer
Gilead Sciences’ subsidiary Kite has agreed to use Sangamo Therapeutics’ zinc finger nuclease (ZFN) technology platform to develop cancer treatments in a collaboration deal worth over $3bn.
Drug Research > Drug Discovery & Development > News
Emulate, Roche partner to apply organ-chips to drug efficacy and safety
By PBR Staff Writer
Scientists from Emulate and Roche have partnered to use Organ-Chips for testing of efficacy and safety of new antibody therapeutics and combination therapies.
Drug Research > Drug Discovery & Development > News
91-105 of 4699 results